Northstar Financial Companies’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$425K Buy
17,634
+7
+0% +$183 0.29% 70
2026
Q1
$495K Sell
17,627
-6,150
-26% -$164K 0.39% 61
2025
Q4
$592K Sell
23,777
-1,034
-4% -$26.1K 0.47% 56
2025
Q3
$632K Sell
24,811
-631
-2% -$15.6K 0.59% 42
2025
Q2
$617K Sell
25,442
-6,468
-20% -$151K 0.64% 38
2025
Q1
$809K Sell
31,910
-282
-0.9% -$7.38K 0.88% 31
2024
Q4
$854K Buy
+32,192
New +$873K 0.81% 26

Other funds holding PFE

Northstar Financial Companies's PFE Position: Q2 2026 in Review

Northstar Financial Companies increased its Pfizer (PFE) stake by 0.04% in Q2 2026, buying an estimated $183 and bringing the position to 17,634 shares worth $425K. The position accounts for 0.29% of the portfolio, ranked #70.

Northstar Financial Companies first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $854K in Q4 2024. 1,694 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Northstar Financial Companies held 17,634 shares of Pfizer worth $425K as of Q2 2026.
  • Northstar Financial Companies bought 7 Pfizer shares in Q2 2026, an estimated $183.
  • Pfizer made up 0.29% of Northstar Financial Companies's portfolio in Q2 2026, its #70 holding.
  • Northstar Financial Companies first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Northstar Financial Companies's Pfizer position peaked at $854K in Q4 2024.
  • 1,694 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Northstar Financial Companies's 13F filing for Q2 2026, filed 6 Aug 2026.